Andrew J. Macadam

South Mimms, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Author Correction: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.

Author Correction: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.

Journal: NPJ vaccines
Published: May 29, 2026

Higher stability of novel live-attenuated oral poliovirus type 2 (nOPV2) despite the emergence of a neurovirulent double recombinant strain in Uganda.

Higher stability of novel live-attenuated oral poliovirus type 2 (nOPV2) despite the emergence of a neurovirulent double recombinant strain in Uganda.

Journal: Nature microbiology
Published: April 17, 2025

Non-lytic spread of poliovirus requires the nonstructural protein 3CD.

Non-lytic spread of poliovirus requires the nonstructural protein 3CD.

Journal: mBio
Published: December 12, 2024

Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.

Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.

Journal: NPJ vaccines
Published: November 07, 2024

Non-lytic spread of poliovirus requires the nonstructural protein 3CD.

Non-lytic spread of poliovirus requires the nonstructural protein 3CD.

Journal: bioRxiv : the preprint server for biology
Published: October 28, 2024

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines.

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines.

Journal: Nature communications
Published: May 06, 2024

The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens.

The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens.

Journal: The Journal of infectious diseases
Published: October 18, 2023

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

Journal: The Journal of general virology
Published: June 30, 2023

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

Journal: bioRxiv : the preprint server for biology
Published: February 13, 2023

Publisher Correction: A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.

Publisher Correction: A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.

Journal: Communications biology
Published: December 23, 2022

Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3.

Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3.

Journal: Nature
Published: November 23, 2022

Thermal stabilization of enterovirus A 71 and production of antigenically stabilized empty capsids.

Thermal stabilization of enterovirus A 71 and production of antigenically stabilized empty capsids.

Journal: The Journal of general virology
Published: August 23, 2022
Showing 1-12 of 33

Last Updated: 09/26/2026